The Effects of an IL-21 Receptor Antagonist on the Alloimmune Response in a Humanized Mouse Skin Transplant Model-Reference-Cited by-同舟云学术

The Effects of an IL-21 Receptor Antagonist on the Alloimmune Response in a Humanized Mouse Skin Transplant Model

Published:2019-10 Issue:10 Volume:103 Page:2065-2074
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

de Leur Kitty,Luk Franka,van den Bosch Thierry P.P.,Dieterich Marjolein,van der Laan Luc J.W.,Hendriks Rudi W.,Clahsen-van Groningen Marian C.,Issa Fadi,Baan Carla C.,Hoogduijn Martin J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference43 articles.

1. Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.;Coemans;Kidney Int,2018

2. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology.;Loupy;Am J Transplant,2017

3. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.;Wiebe;Am J Transplant,2015

4. Antibody-mediated vascular rejection of kidney allografts: a population-based study.;Lefaucheur;Lancet,2013

5. Novel immunotherapeutic strategies to target alloantibody-producing B and plasma cells in transplantation.;Inaba;Curr Opin Organ Transplant,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of the Immune System with Human Kidney Organoids;Transplant International;2024-04-18

2. Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody–mediated rejection showing a new link between adaptive and innate humoral allo-immunity;Kidney International;2023-10

3. CAR-T Cells: A New Tool for Monitoring T-cell Alloreactivity?;Transplantation;2023-08-02

4. Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients;Transplantation Direct;2023-04-20

5. Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection;Trends in Molecular Medicine;2022-03